Amgen Ventures
Status
ACTIVE
Global HQ
California, United States
Countries of investment
- USA
Investment stages
- Series A
- Series B
Industries
- Pharma
- Digital Health
- Health Tech
About
AmgenBD is a biotech company specializing in innovative therapies for cancer, cardiovascular diseases, and inflammatory conditions through biologics and biosimilars.
AmgenBD is a biotech company specializing in innovative therapies for cancer, cardiovascular diseases, and inflammatory conditions through biologics and biosimilars.
Investment Thesis
Amgen Focuses on investing in innovative biotechnology and pharmaceutical companies that align with Amgen’s strategic interests and advance medical science.
Manager's Experience
Specializes in early-stage investments across technology, fintech, and health sectors. Known for a strong presence in North America and Europe, having backed over 50 startups. Focused on creating value through strategic partnerships and operational support. Recognized for a disciplined investment approach that prioritizes scalable business models and sustainable growth.